Chesapeake installs Mark Andy P7 new flexo label press at its Fairfield, New Jersey, site; manager says press will support growth plans, extend capabilities, such as greater range of labels with complex designs requiring high number of colors

OLD AMERSHAM, England , October 22, 2012 (press release) – Chesapeake, a leading global manufacturer of pharmaceutical and healthcare packaging, has invested in a new Mark Andy P7 flexo label press which has been installed at its Fairfield site in New Jersey. Gene Lepelletier, Fairfield’s Operations Manager, commented, “The new Mark Andy press will support our growth plans and extend our capabilities. We can now produce a greater range of labels particularly complex designs requiring a high number of colours. The P7 press is also equipped with many quality control and time-saving features which will help us strengthen the quality and service levels we deliver to our customers.”

The Mark Andy P7 flexo press is equipped with 8 UV and Hot Air flexo print units. The machine set-up is fully automated, print quality is monitored and adjusted at any manufacturing speed across a full range of substrates. The Mark Andy P7 is ideal for short run lengths where a rapid changeover is essential.

The new press investment is part of a major global investment program which has benefited all Chesapeake’s site including the installation of additional equipment at operations in Evansville, Lexington, Long Island and Raleigh. Gene went onto say, “We were immediately impressed with the increased automation and environmental related improvements. The inline quality inspection system from AVT as well as the automatic register functions of the new press will enable us to maintain even greater product consistency for our customers. The efficiency improvements will also significantly reduce both ink and material waste helping us to meet our environmental goals.”

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.